These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 21477078)
1. Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition. Cohen-Solal KA; Merrigan KT; Chan JL; Goydos JS; Chen W; Foran DJ; Liu F; Lasfar A; Reiss M Pigment Cell Melanoma Res; 2011 Jun; 24(3):512-24. PubMed ID: 21477078 [TBL] [Abstract][Full Text] [Related]
2. Non-canonical Smads phosphorylation induced by the glutamate release inhibitor, riluzole, through GSK3 activation in melanoma. Abushahba W; Olabisi OO; Jeong BS; Boregowda RK; Wen Y; Liu F; Goydos JS; Lasfar A; Cohen-Solal KA PLoS One; 2012; 7(10):e47312. PubMed ID: 23077590 [TBL] [Abstract][Full Text] [Related]
3. Requirement of a dynein light chain in TGFbeta/Smad3 signaling. Jin Q; Gao G; Mulder KM J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells. van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-{beta}-inducible phosphorylation of Smad3. Wang G; Matsuura I; He D; Liu F J Biol Chem; 2009 Apr; 284(15):9663-73. PubMed ID: 19218245 [TBL] [Abstract][Full Text] [Related]
6. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor. Zhang L; Sato E; Amagasaki K; Nakao A; Naganuma H J Neurosurg; 2006 Jul; 105(1):119-28. PubMed ID: 16871886 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. Rich JN; Zhang M; Datto MB; Bigner DD; Wang XF J Biol Chem; 1999 Dec; 274(49):35053-8. PubMed ID: 10574984 [TBL] [Abstract][Full Text] [Related]
8. Involvement of deterioration in S100C/A11-mediated pathway in resistance of human squamous cancer cell lines to TGFbeta-induced growth suppression. Sonegawa H; Nukui T; Li DW; Takaishi M; Sakaguchi M; Huh NH J Mol Med (Berl); 2007 Jul; 85(7):753-62. PubMed ID: 17476473 [TBL] [Abstract][Full Text] [Related]
9. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. Feng XH; Lin X; Derynck R EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220 [TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells. Zelivianski S; Cooley A; Kall R; Jeruss JS Mol Cancer Res; 2010 Oct; 8(10):1375-87. PubMed ID: 20736297 [TBL] [Abstract][Full Text] [Related]
11. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer. Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654 [TBL] [Abstract][Full Text] [Related]
12. The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling. Liang J; Zhou Y; Zhang N; Wang D; Cheng X; Li K; Huang R; Lu Y; Wang H; Han D; Wu W; Han M; Miao S; Wang L; Zhao H; Song W J Biol Chem; 2021; 296():100512. PubMed ID: 33676893 [TBL] [Abstract][Full Text] [Related]
13. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2. Giannouli CC; Kletsas D Cell Signal; 2006 Sep; 18(9):1417-29. PubMed ID: 16361081 [TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling. Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232 [TBL] [Abstract][Full Text] [Related]
16. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434 [TBL] [Abstract][Full Text] [Related]
17. Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place? Lasfar A; Cohen-Solal KA Carcinogenesis; 2010 Oct; 31(10):1710-7. PubMed ID: 20656791 [TBL] [Abstract][Full Text] [Related]
18. Interaction of ERK1/2 and Smad2/3 signaling pathways in TGF-β1-induced TIMP-3 expression in rat chondrocytes. Wang X; Zhu Y; Tao H; Jin C; Liu Y; Lu X; Hu X; Fan C Arch Biochem Biophys; 2014 Dec; 564():229-36. PubMed ID: 25245272 [TBL] [Abstract][Full Text] [Related]
19. Osteoarthritis-Related Inflammation Blocks TGF-β's Protective Effect on Chondrocyte Hypertrophy via (de)Phosphorylation of the SMAD2/3 Linker Region. Thielen N; Neefjes M; Wiegertjes R; van den Akker G; Vitters E; van Beuningen H; Blaney Davidson E; Koenders M; van Lent P; van de Loo F; van Caam A; van der Kraan P Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360888 [TBL] [Abstract][Full Text] [Related]
20. TGFβ-induced early activation of the small GTPase RhoA is Smad2/3-independent and involves Src and the guanine nucleotide exchange factor Vav2. Papadimitriou E; Kardassis D; Moustakas A; Stournaras C Cell Physiol Biochem; 2011; 28(2):229-38. PubMed ID: 21865730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]